Hong Kong Beverage Stock News

Chow Tai Fook Jewellery Group (SEHK:1929) is in focus after the passing of independent non executive director Mr. Kwong Che Keung, Gordon. He also chaired the audit committee and sat on the remuneration committee. See our latest analysis for Chow Tai Fook Jewellery Group. Chow Tai Fook Jewellery Group’s recent governance shock comes as the stock trades at HK$12.03, with a 1 day share price return of 1.78% and a 7 day share price return of 5.43%. Over the same period, the 1 year total...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

China Lesso Group Holdings Limited ( HKG:2128 ), is not the largest company out there, but it saw a decent share price...

While Harbin Electric Company Limited ( HKG:1133 ) might not have the largest market cap around , it saw significant...

Viewing insider transactions for Hang Lung Group Limited's ( HKG:10 ) over the last year, we see that insiders were net...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Last week, China Uptown Group Company Limited ( HKG:2330 ) insiders, who had purchased shares in the previous 12 months...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Pico Far East Holdings Limited's ( HKG:752 ) robust earnings report didn't manage to move the market for its stock. Our...

Xiaomi’s share price has swung sharply over the past few years, and with the stock up 148.6% over 3 years but still down heavily over the last 12 months, the key tension now is that the Discounted Cash Flow (DCF) intrinsic value estimate points to around 10.1% upside while the broader valuation checks suggest the stock is closer to fairly priced. Xiaomi has returned 148.6% over the past 3 years, which puts the recent weakness in a longer track record of strong gains for long term...

Chevalier International Holdings (SEHK:25) has just posted its FY 2026 results, with first half revenue of HK$3.9 billion and EPS of HK$0.77, while trailing twelve month figures show revenue of HK$8.2 billion and EPS of HK$1.39. Over the past few reporting periods, the company has seen revenue range between HK$4.0 billion and HK$5.2 billion per half year, alongside EPS that has swung from a loss of HK$1.84 per share in FY 2025 H2 to a profit in the latest period. This sets up this release as...

Stella International Holdings (SEHK:1836) reported unaudited revenue growth for the quarter and half year to 30 June 2026, with sales edging higher in both periods compared with the same time last year. See our latest analysis for Stella International Holdings. Stella International Holdings’ HK$12.79 share price has risen over the past week but is still down 6.2% over 30 days and 16.5% over 90 days. However, the 3 year total shareholder return of 119.9% and 5 year total shareholder return of...

China Mobile (SEHK:941) is back in focus after HKBN Ltd. renewed and expanded its Master Agreements with China Mobile Hong Kong and China Mobile International, extending a broad range of telecom and technology services to 2028. See our latest analysis for China Mobile. The HKBN renewal arrives while China Mobile’s share price has slipped, with a 30 day share price return of 2.09% decline and a year to date share price return of 4.61% decline, even as the 5 year total shareholder return of...

China National Building Material (SEHK:3323) issued unaudited guidance for the six months to 30 June 2026, flagging an expected RMB 890 million loss compared with a RMB 1,360 million profit a year earlier. See our latest analysis for China National Building Material. The guidance lands after a weak run for China National Building Material's stock, with the share price down 27.41% over 30 days and the 1 year total shareholder return declining 8.64%, while the 3 year total shareholder return is...

Innovent Biologics recently announced an exclusive license agreement granting Spero Therapeutics rights to develop and commercialize IBI355 outside Greater China, with Innovent eligible for up to approximately US$1.10 billion in upfront and milestone payments plus tiered royalties. The arrangement effectively turns IBI355 into a globally partnered asset, allowing Innovent to keep Greater China rights while leveraging Spero’s international development plans in IgG4-related disease and...

Q Technology (Group) (SEHK:1478) reported unaudited June 2026 sales data, with 41,500,000 camera module and LiDAR units and 11,961,000 biological recognition modules shipped, giving investors fresh insight into current operating activity. See our latest analysis for Q Technology (Group). At a share price of HK$7.01, Q Technology (Group) has seen short term momentum soften, with a 1 month share price return down 22.54% and year to date share price return down 18.96%, even though the 3 year...

Geely Automobile Holdings (SEHK:175) has expanded its partnership with Valvoline Global Operations, naming Valvoline as its designated lubricant technology partner across Asia Pacific. The agreement includes Geely’s Horse Powertrain joint venture and provides Valvoline with long term aftersales access across Geely’s vehicle network. Geely is also part of a surge in Chinese car exports that recently crossed 1,000,000 units in a single month, as European trade pressures prompt automakers to...

Guangzhou Innogen Pharmaceutical Group Co., Ltd ( HKG:2591 ) is possibly approaching a major achievement in its...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

With the business potentially at an important milestone, we thought we'd take a closer look at Jiangsu Guofu Hydrogen...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Insiders who bought HK$11.1m worth of B.Duck Semk Holdings International Limited's ( HKG:2250 ) stock at an average buy...

With the business potentially at an important milestone, we thought we'd take a closer look at Keymed Biosciences...

With the business potentially at an important milestone, we thought we'd take a closer look at CiDi Inc.'s ( HKG:3881...